Drug discovery companies identify, validate and develop new therapeutic candidates for the prevention and treatment of disease. The sector combines biology, chemistry, data science and clinical expertise to bring new medicines from concept to clinic.
This category includes companies working on:
Browse 422 UK drug discovery companies below.
GPR35 inhibitors for gastrointestinal cancer and inflammatory bowel disease
ThirtyFiveBio is a drug discovery company developing first-in-class small molecule inhibitors of GPR35, a genetically validated G protein-coupled receptor implicated in…
Mass spectrometry proteomics and multi-omics contract research services
Platinum Discovery is a contract research organisation providing large-scale, mass spectrometry-based proteomics and multi-omics research services to pharmaceutical, biotech, and…
AI-guided plant biosynthesis platform for novel therapeutic compounds
HotHouse Therapeutics is a drug discovery platform company that engineers plants as sustainable biofactories for pharmaceutical compound production. Using AI to design and…
Tissue-level disease platform for endometriosis drug discovery
Cyclana Bio is a drug discovery company developing tissue-level therapeutics for endometriosis and women's health conditions. The company builds whole-tissue disease models using…
KnotBody therapeutics for ion channel and GPCR diseases
Maxion Therapeutics is a biotechnology company developing a pipeline of KnotBody therapeutics for diseases driven by ion channel and G protein-coupled receptor dysfunction. The…
High-throughput iPSC reprogramming and stem cell drug discovery services
Oxford StemTech is a contract research company providing induced pluripotent stem cell (iPSC) reprogramming and drug discovery services using its proprietary platform. The…
TSG-6 protein therapeutics for inflammatory and degenerative disease
Link Biologics is a preclinical-stage biotechnology company developing protein therapeutics based on TSG-6, an endogenous human protein with anti-inflammatory and…
Therapeutics targeting lysosomal dysfunction in neurodegeneration
Endlyz Therapeutics is a preclinical-stage biotechnology company developing small molecule modulators to restore endo-lysosomal function in Parkinson's disease and related…
Genetic biomarker discovery platform for precision medicine and diagnostics
Population Bio is a genomic discovery company providing genetic biomarker identification services to pharmaceutical and biotechnology partners. Its platform accelerates the…
Deep learning platform for small molecule drug discovery
CHARM Therapeutics is a clinical-stage biotechnology company applying 3D deep learning to small molecule drug discovery. Its proprietary platform uses protein-ligand co-folding…
T cell-engaging multispecific antibody fragments for solid tumours
Crescendo Biologics is a clinical-stage biopharmaceutical company developing multispecific therapeutics based on fully human single-domain antibody fragments engineered for…
Oral muscle-sparing small molecule therapies for obesity
Hawkhill Therapeutics is a pre-clinical biotechnology company developing oral, muscle-sparing therapeutics for obesity and metabolic health. Its programme targets a clinically…